In an era where technology is redefining the boundaries of medicine, Dr. Karla Noemi Duka, a Resident Physician specializing in Diabetes, Nutrition, and Metabolic Diseases at the Târgu Mureș County Emergency Clinical Hospital, offers us a unique perspective on integrating digital innovation into everyday medical practice. We talked with Dr. Duka about her experience with Diabeta, the first medical chatbot dedicated to diabetologists in Romania, and its impact on diabetes management.
“I learned about Diabeta from my colleague and friend, who participated in developing this extremely useful tool for all doctors,” Dr. Karla Noemi Duka tells us. Diabeta is an innovative chatbot designed to provide continuous support and education to doctors in the field of diabetology, facilitating quick access to updated and verified information.
Referring to the initiative of creating the medical chatbot, Dr. Duka highlighted its multiple advantages: “It is extremely valuable and innovative, offering accessibility, availability, continuous education, precision, and reliability.”
When asked about the essential aspect that caught her attention, Dr. Karla Noemi Duka pointed out the credibility of the information provided by the chatbot: “Being approved by ANMDM and using official sources, the chatbot offers correct and verified information, ensuring user trust.”
Dr. Karla Noemi Duka believes that Diabeta can significantly reduce the time needed for diabetes management: “The doctor can access updated information about diabetes treatments at any time, thus reducing the time needed to find this information through traditional methods.”
Looking to the future, Dr. Duka suggests regular content updates and continued close collaboration with medical experts, which are essential to ensure that the information and recommendations provided are of the highest quality and accuracy.
Integrating technology into the medical field, exemplified by using Diabeta, represents a major step towards streamlining and optimizing patient care for those with diabetes. Dr. Karla Noemi Duka remains optimistic and enthusiastic about the future of this innovative collaboration between medicine and technology.
DIABETA has benefited from the support of prestigious partners such as Novo Nordisk, Boehringer Ingelheim, and Medtronic. This partnership demonstrates how a local initiative can have a global impact, bringing together resources and experiences to address the challenges related to diabetes.
